Menu

Beyond Next-Generation Sequencing

 A panel of experts will discuss new genomic sequencing technologies for understanding human health and disease. 

The Scientist Creative Services Team
Feb 11, 2020

Beyond Next-Generation Sequencing from thescientistllc on Vimeo

Third-generation sequencing methods promise longer sequence reads without the challenges of genome assembly. Beyond simple DNA sequencing, these technologies can reveal epigenetics, transcriptomics, and metagenomics data. This webinar, brought to you by The Scientist, will explore new sequencing technologies in development that surpass the capability of current next-generation sequencing to help more fully understand human health and disease.

Topics to be covered

  • Solving computational problems in genomics research
  • Applying complex genomics for understanding health and disease

Meet the Speakers:

Michael Schatz, PhD
Bloomberg Distinguished Associate Professor of Computer Science and Biology,
Johns Hopkins University
Adjunct Associate Professor of Quantitative Biology, Cold Spring Harbor Laboratory


Kristin G. Beaumont, PhD
Assistant Professor & Assistant Director of Single Cell Genomics Technology Development
Department of Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
Icahn Institute for Data Science and Genomic Technology



July/August 2020

Life During a Pandemic

Understanding the virus is just the beginning

Marketplace

Sponsored Product Updates

New England Biolabs' SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 Minutes
The research use only kit can be used as a simple alternative to RT-qPCR for SARS-CoV-2 analysis
LI-COR Near-Infrared Assays and Technology Offer Insight to Coronavirus Researchers
The SARS-CoV-2 coronavirus and subsequent COVID-19 pandemic places the subject of viruses and virology in the research spotlight for good reason.
Defeating COVID-19: The Science Behind a New ELISA for COVID-19 Seroconversion Detection
The recent and rapid spread of the novel coronavirus, SARS-CoV-2, has necessitated the development of new assays that are capable of detecting the presence of this virus in patient samples or evidence of recent infection. One strategy being developed are assays to detect the presence of anti-SARS-CoV-2 antibodies in patient sera.
Imaging Multicolor Western Blots
Introducing The FluorChem R Imaging System